Department of Geriatrics, Respiratory Medicine, Xiangya Hospital of Central South University, Changsha, China.
National Clinical Research Center for Geriatric Disorders, Xiangya Hospital of Central South University, Changsha, China.
Clin Respir J. 2020 Jul;14(7):667-674. doi: 10.1111/crj.13182. Epub 2020 Mar 20.
To examine the effects of Keratin 6A (KRT6A) protein on the proliferation, migration and invasion abilities of lung adenocarcinoma cells, and to analyse the relationship between the expression level of KRT6A protein and the survival prognosis of lung adenocarcinoma patients.
Western Blot was used to detect the expression of KRT6A protein in lung adenocarcinoma cell lines. CCK-8 experiment and colony formation assays were performed to detect the proliferation ability. Wound healing assay and transwell migration assay were conducted to detect the migration ability. Transwell invasion assay was conducted to detect the invasion ability. Immunohistochemistry was used to detect the expression of KRT6A protein in lung adenocarcinoma tissues.
We first found that the expression of KRT6A protein in lung adenocarcinoma cell lines was low. After overexpressed KRT6A protein in lung adenocarcinoma cells, we then found that KRT6A protein could not only inhibit the proliferation ability of lung adenocarcinoma cells but also inhibit them migration and invasion abilities. In addition, we also found that there had obvious difference in the expression of KRT6A protein in between patients. And through further analysis, we finally discovered that high expression of KRT6A protein was related to favourable prognosis in lung adenocarcinoma patients.
KRT6A protein inhibits the proliferation, migration and invasion abilities of lung adenocarcinoma cells, and high expression of KRT6A protein is a predictor of good prognosis in patients with lung adenocarcinoma.
研究角蛋白 6A(KRT6A)蛋白对肺腺癌细胞增殖、迁移和侵袭能力的影响,并分析 KRT6A 蛋白表达水平与肺腺癌患者生存预后的关系。
采用 Western blot 检测肺腺癌细胞系中 KRT6A 蛋白的表达。CCK-8 实验和集落形成实验检测细胞增殖能力。划痕愈合实验和 Transwell 迁移实验检测细胞迁移能力。Transwell 侵袭实验检测细胞侵袭能力。免疫组化检测肺腺癌组织中 KRT6A 蛋白的表达。
我们首先发现肺腺癌细胞系中 KRT6A 蛋白的表达较低。过表达肺腺癌细胞中的 KRT6A 蛋白后,我们发现 KRT6A 蛋白不仅能抑制肺腺癌细胞的增殖能力,还能抑制其迁移和侵袭能力。此外,我们还发现 KRT6A 蛋白在肺腺癌患者之间的表达存在明显差异。通过进一步分析,我们最终发现 KRT6A 蛋白的高表达与肺腺癌患者的良好预后相关。
KRT6A 蛋白抑制肺腺癌细胞的增殖、迁移和侵袭能力,KRT6A 蛋白的高表达是肺腺癌患者预后良好的预测指标。